Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Schütz-Fuhrmann, I; Stadler, M; Zlamal-Fortunat, S; Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, SE; Mader, J; Resl, M; Bischof, M; Kautzky-Willer, A; Weitgasser, R.
[Insulin pump therapy in children, adolescents and adults, guidelines (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):47-53
Doi: 10.1007/s00508-019-1485-6
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Fröhlich-Reiterer Elke
- Mader Julia
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- This position statement is based on current evidence available on the safety and benefits of continuous subcutaneous insulin infusion therapy (CSII, pump therapy) in diabetes with an emphasis on the effects of CSII on glycemic control, hypoglycaemia rates, occurrence of ketoacidosis, quality of life and the use of insulin pump therapy in pregnancy. The current article represents the recommendations of the Austrian Diabetes Association for the clinical praxis of insulin pump treatment in children, adolescents and adults.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Adult -
- Adult -
- Child -
- Diabetes Mellitus, Type 1 - drug therapy
- Female -
- Humans -
- Hypoglycemic Agents - administration & dosage
- Hypoglycemic Agents - therapeutic use
- Infusion Pumps, Implantable -
- Insulin -
- Insulin Infusion Systems -
- Male -
- Practice Guidelines as Topic -
- Quality of Life -
- Find related publications in this database (Keywords)
- Insulin pump therapy
- Guidelines diabetes mellitus
- Children and adolescents with diabetes